AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

A viral outbreak in China is raising concerns reminiscent of 2019, but this time the focus is on human metapneumovirus (HMPV) ...

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

The Hailie Smartinhaler device has also been cleared for use with inhalers from other manufacturers ... the device directly to patients with asthma and COPD under a 510(k) over-the-counter ...

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

“Emphysema makes it hard to breathe air out of your lungs as it affects the tiny air sacs at the end of the airways where ...

Winter is closely linked to an increase in respiratory infections, as it is considered a season of heightened allergies and ...

As the doctors told Annette Stalley she might need to be put on a ventilator, she realised it was a situation of her own ...

“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Breathe helps relieve symptoms of asthma and COPD, promotes deeper breathing, targets mucus buildup, and provides a natural alternative to inhalers and steroids. Breathe is made from natural ...